Resources

Operational Processes and Challenges in Germline Testing Webinar

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 6

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay

Role of ctDNA in Germline Testing

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 5

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay

Identification of Patients for Germline Testing

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 4

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay

Tumor-Normal Matched Sequencing and Platforms Utilized for Tumor Profiling

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 2

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay

Defining Germline Sequencing and Incidental Germline Findings

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 1

Speakers: Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

Watch replay